A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function
Clinical trial NCT05610657 · COMPLETED
Trial details
- NCT number
- NCT05610657
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-10
- Primary completion
- 2023-07-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.